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In the epidemiology of tuberculosis (TB) and nontuberculous mycobacterial (NTM) diseases, as in all infectious diseases, the key
issue is to define the source of infection and to disclose its routes of transmission and dissemination in the environment. For this
to be accomplished, the ability of discerning and tracking individual Mycobacterium strains is of critical importance. Molecular
typing methods have greatly improved our understanding of the biology of mycobacteria and provide powerful tools to combat the
diseases caused by these pathogens.Theutility of various typingmethods depends on theMycobacterium species under investigation
as well as on the research question. For tuberculosis, different methods have different roles in phylogenetic analyses and person-to-
person transmission studies. In NTM diseases, most investigations involve the search for environmental sources or phylogenetic
relationships. Here, too, the type of setting determines which methodology is most suitable. Within this review, we summarize
currently available molecular methods for strain typing of M. tuberculosis and some NTM species, most commonly associated
with human disease. For the various methods, technical practicalities as well as discriminatory power and accomplishments are
reviewed.
1. Introduction
The genusMycobacterium contains more than 140 species [1],
which are separated in three major groups, that is,M. tuber-
culosis complex (MTBC), M. leprae, and mycobacteria other
than MTBC and M. leprae, collectively referred to as nontu-
berculousmycobacteria (NTM).Mycobacterium tuberculosis,
the most prominent member of the MTBC, is an obligate
humanpathogen and the causative agent of tuberculosis (TB),
which remains one of the leading global public health prob-
lems. According to the World Health Organization (WHO),
over 9 million new cases of TB occur each year, resulting in
approximately 2 million deaths worldwide [2]. Conversely to
M. tuberculosis, for which no environmental reservoir exists,
NTM are ubiquitous organisms and are readily isolated from
environmental sources, including soil and both natural and
artificial water systems [3]. Despite reportedly low virulence
of NTMs for immunocompetent human hosts, an increase in
their isolation frequencies has been seen in the last decade,
particularly in countries where TB incidence is on decrease
[4, 5].
In the epidemiology of TB and other mycobacterioses, as
in all infectious diseases, the key issue is to define the source
of infection and to disclose its routes of transmission and
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dissemination in the environment. For this to be accom-
plished, the ability of discerning and tracking individual
Mycobacterium strains is of critical importance. The earliest
discriminatory methods relied upon phenotypic characteris-
tics, such as colonymorphology, susceptibility to antitubercu-
losis drugs, or mycobacterial phage typing. The usefulness of
thesemethods is seriously limited by the phenotypic variabil-
ity of mycobacteria. For instance, drug susceptibility patterns
may change for the same isolate as it acquires resistance
to specific drugs in the course of treatment. Otherwise, the
limiting factor of phage typing is the low number of rec-
ognized mycobacteriophages [6–8]. Discrimination between
the strains based on their biochemical and serological char-
acteristics is even more unsuccessful [9, 10]. A turning point
in this quest was the development of molecular biology tools
in the mid 1980s. The DNA-based techniques have revolu-
tionized the epidemiology of TB and other mycobacterial
diseases, since they allow querying the whole genome that is
unique and relatively stable for each strain.
In terms of genetic heterogeneity, the MTBC and NTM
are vastly different and this has strong implications for the
choice of typingmethods and the achievable levels of discrim-
ination.
Mycobacterium tuberculosis complex constitutes a
remarkably genetically homogeneous group. This is perhaps
best illustrated by the fact that, within the ribosomal DNA
(rDNA) operon, not only genes encoding various types of
rRNA but also regions between those genes, such as internal
transcribed spacer (ITS) regions, which in many bacteria
and fungi are highly polymorphic and thus are useful for
identification and typing to subspecies or strain level, show
complete conservation among members of the M. tubercu-
losis complex [11]. Likewise, many structural genes of M.
tuberculosis complex show important sequence conservation,
with an estimated rate of synonymous mutations of 0.01–
0.03% [12–14]. Additionally, the lack of significant evidence
for horizontal gene transfer betweenM. tuberculosis genomes
speaks in favor of clonal evolution inM. tuberculosis complex
[12–15]. This in turn renders strain-level discrimination of
M. tuberculosis by means of molecular typing approaches
challenging. However, recent studies have shown that the
genetic diversity of theMTBC ismuch higher than previously
assumed and that this genomic variance is attributed to the
single nucleotide polymorphisms (SNPs), with potential
impact on pathobiological phenotype [16, 17].
As for the NTM, the evolutionary time of divergence is
believed to be much larger than that for the M. tuberculosis
complex and this implies that less than awhole genome can be
queried to obtain a highly discriminatory typing result [18].
Within this review, we summarize currently available
molecular methods for strain typing of mycobacteria. For
the various techniques, technical practicalities as well as
discriminatory power and accomplishments are reviewed.
2. Restriction Site Analysis of Genomic DNA
First attempts of molecular typing of M. tuberculosis were
based on restriction enzyme analysis of bacterialDNA (REA).
In principle, chromosomal DNA of the analyzed strains is
digested using various restriction enzymes and the resulting
fragments are separated and visualized by gel electrophoresis.
The obtained pattern of DNA fragments (genetic fingerprint)
is characteristic for each strain. However, using the original
procedure, the sensitivity of the method is rather limited due
to technical difficulties in providing a high-resolution elec-
trophoretic separation of fragments within a broad range of
sizes. Also, whenmore restriction enzymes are used, the high
number of DNA fragments makes a reliable analysis impos-
sible [19]. Therefore, new methods have been proposed for a
more accurate separation of DNA molecules, such as REA-
PFGE (pulsed-field gel electrophoresis), which guarantees
high resolution of the restriction patterns. More commonly
used methods, which are modifications of the traditional
REA, employ DNA hybridization assay in the process of
specific pattern detection. Specifically, after electrophoresis,
the separated DNA fragments are denatured in situ and
transferred onto a membrane, which is then incubated with
a radiolabeled probe (Southern blot) for the target sequence.
Hybridization signals are visualized on autoradiography. The
Southern blot technique was first applied to the analysis of
restriction fragment length polymorphism (RFLP), which is
hence a combination of REA and hybridization technology.
Early studies utilizing RFLP methodology indicated that
strains ofM. tuberculosis display a considerably low degree of
genetic diversity. However, such interpretation of the results
was actually misleading since probes used in those studies
targeted highly conserved regions and were of low specificity
[20–22]. The resolution of the RFLP method increased
substantially when insertion sequences (IS) were identified
and used in probe construction [23, 24]. Different repetitive
sequences found in the genomes of M. tuberculosis and
NTM are an important source of genetic polymorphism
and provide reliable markers allowing the determination of
genetic relationships at both species and strain levels.
3. Pulsed-Field Gel Electrophoresis (PFGE)
A method related to REA, pulsed-field gel electrophoresis
(PFGE), enables the separation of large DNA fragments, up
to 10Mb. In contrast, by using conventional electrophoresis,
the threshold length exists at about 50 kb.The principle of the
PFGE system is based on the application of an electric field
that periodically changes its orientation across a gel matrix.
This is achieved by varying the duration of the electrical pulse
and shifting the direction of the current frequently. In general,
the PFGE procedure involves digestion of chromosomal
DNA with rare cutting restriction endonucleases, followed
by agarose gel electrophoresis and analysis of the resolved
electrophoretic patterns. A crucial step is the preparation of
genomic DNA. Since large DNA molecules are prone to
shearing and crushing, DNA is isolated in a gentle manner
by first embedding a suspension of the organism in agarose
plugs, lysing the cells in situ, and digesting the chromosomal
DNA with restriction enzymes. The plugs are then loaded
into the gel wells and sealed into place with agarose. After the
electrophoresis, the resulting banding patterns are compared,
using a predefined set of criteria for strain relatedness [25].
Although the PFGE patterns are well reproducible and the
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overall discriminatory power of themethod is high, a number
of limitations are apparent. Firstly, the method is technically
demanding and cost intensive. Secondly, it requires intact
DNA for restriction enzyme treatment. Thirdly, the PFGE
method has a long turn-over time, as the whole protocol
usually takes not less than a week. Finally, no standardized
procedure for performing PFGE has yet been recommended.
Despite these disadvantages, the PFGE typing was success-
fully used to differentiate between strains of M. tuberculosis
[26], M. bovis [27], and M. bovis BCG [28]. However, the
PFGE typing is rarely used inM. tuberculosis complex due to
technical, time, and cost considerations, as mentioned above.
Moreover, PFGE analysis does not always generate sufficient
discrimination between the strains [26, 29, 30].
Quite oppositely, PFGE often remains the most powerful
typing system for nontuberculousmycobacteria.Themethod
has been applied, with different degrees of success, to both
slow-growing NTM species, including M. kansasii [31, 32],
M. avium-M. intracellulare complex [33], M. gordonae [34],
andM.haemophilum [35], and rapidly growingmycobacteria,
such asM. fortuitum [36],M. chelonae [37], andM. abscessus
[37, 38].
4. IS6110-RFLP Analysis
Study of the completeM. tuberculosis H
37
Rv reference strain
genome sequence revealed a relatively large amount of
repetitive DNA elements [39].Those elements vary in length,
structure, and localization. Two main groups can be dis-
tinguished, that is, tandem repeats (TR) and interspersed
repeats (IR). The first are short monomeric sequences (up to
100 bp) organized as head-to-tail arrays, whereas the latter are
scattered as individual copies throughout the entire genome.
An important class of IR sequences is insertion sequences
(IS), which are mobile genetic elements.
The best known and investigated insertion sequence is
IS6110 first recognized by Thierry et al. in the early 1990s
[40–43]. The IS6110 sequence belongs to the IS3 family and
is a 1,355 bp long with unique 28 bp terminal inverted repeats
(TIR). The region between those repeats includes two over-
lapping reading frames, orfA and orfB, encoding for a trans-
posase, an enzyme responsible for transposition of the inser-
tion sequence. The IS6110 is found within theM. tuberculosis
complex, and, inmost members of the complex, the sequence
is present at multiple copies, although M. bovis normally
contains only one copy. In general, the copy number of
IS6110 ranges from 0 to 25 and depends on the frequency
of transposition, which is largely conditioned by the nature
of the genomic region at which transposition occurs [44].
Although the IS6110 can be integrated into any place on
the chromosome, there are regions with higher frequency of
transposition. The so-called integration hot spots are usually
located within coding regions of M. tuberculosis DNA [44,
45].
Differences in the copy number and locations within the
genome, responsible for the high degree of IS6110 polymor-
phism, have predisposed this sequence to be used as a specific
molecular marker for genotyping of M. tuberculosis strains
[46, 47].
IS6110-based typing is still among themost widely applied
genotyping methods in molecular epidemiological studies of
M. tuberculosis. The method includes digestion of genomic
DNA with PvuII restriction enzyme that cleaves the IS6110
sequence only once, generating DNA fragments that are
separated through gel electrophoresis, then transferred onto a
membrane, and hybridized with a peroxidase-labelled probe
complementary to part of the 3󸀠-end of the IS6110 sequence.
As a result, every visualized fragment represents a single
copy of IS6110 surrounded by different in length flanking
DNA (Figure 1(1)) [48]. Since the IS6110-RFLP methodology
has been standardized and published, recommendations have
been adopted bymost of the research groups; the fingerprints
generated in different laboratories can be compared and
catalogued [49, 50].Themethod is highly discriminatory and
reproducible. An important characteristic of IS6110-RFLP
typing is the stability of its profiles over time, allowing dis-
tinguishing epidemiologically related fromunrelated isolates.
Specifically, the half-time of change in IS6110-RFLP pattern
was estimated to be ca. 3-4 years [51, 52]. Stability of the
IS6110-RFLP patterns depends on the transposition process
frequency; the more common is the transposition, the less
stable is the number of the IS6110 element in the genome.
However, several important limitations exist for the IS6110-
RFLP method. Firstly, there is a need for large amounts of
high quality DNA (2𝜇g) for restriction enzyme digestion
and therefore requires time consuming (up to several weeks)
bacterial culturing. Secondly, the method is technically
demanding and requires sophisticated and expensive com-
puter software as well as experienced personnel of high
technical expertise. Finally, the discriminatory power of
IS6110-RFLP typing is insufficient for those strains whose
copy number of IS6110 is 6 or less (the so-called low-copy
strains are seen among M. bovis isolates from cattle or M.
tuberculosis isolates from Asia) [53–56]. In addition, some
NTM have multiple copies of sequences that are homologous
to IS6110 and may thus hybridize with the IS6110 probe [57].
Despite these limitations, the IS6110-RFLP method
remains one of the most commonly used approaches for M.
tuberculosis typing andwas long considered the gold standard
technique in the molecular epidemiological investigations of
TB.
5. IS6110-Based PCR Fingerprinting
The IS6110 is a target sequence in many methods currently
used for molecular typing of M. tuberculosis. Among these,
the most important is the mixed-linker PCR (ML-PCR) [58],
ligation-mediated PCR (LM-PCR) [60], and fast ligation-
mediated PCR (FliP) [59]. All these methods follow a similar
four-step algorithm including genomic DNA fragmentation
using restriction enzymes that generate protruding ends (i),
ligation of those fragments with synthetic oligonucleotide
linkers or adaptors (ii), amplification of the ligation products
with one primer specific for the IS6110 and a second primer
complementary to a linker (iii), and analysis of the amplicons
(iv).
In ML-PCR and FliP methods the products are 3󸀠 frag-
ments of IS6110, whereas in LM-PCR the IS6110-flanking
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Figure 1: Schematic representation of the chromosome of a hypotheticalMycobacterium tuberculosis complex isolate with marked repetitive
elements as targets for different typing methods. The principle of those methods is pictorially outlined. (1) In IS6110-RFLP typing,
mycobacterial DNA is cleaved with the restriction endonuclease PvuII, and the resulting fragments are separated electrophoretically on an
agarose gel, transferred onto a nylon membrane by Southern blotting, and hybridized to a probe complementary to the 3󸀠-end of the IS6110
(probe target) yielding a characteristic banding pattern, in which every band represents a single IS6110 element. (2) Spoligotyping relies
upon PCR amplification of a single direct repeat (DR) locus which harbours 36 bp direct repeats interspersed with unique 34–41 bp spacer
sequences. The PCR products (red horizontal lines) are hybridized to a membrane containing 43 oligonucleotides corresponding to the
spacers fromM. tuberculosis H
37
Rv andMycobacterium bovis BCG. The presence or absence of each of those 43 spacers in the DR region of
the analysed isolate will be represented as the pattern of positive or negative hybridization signals. (3)The variable numbers of tandem repeat
loci (VNTR) or mycobacterial interspersed repetitive units (MIRU) are PCR-amplified and the obtained products (yellow horizontal line)
are sized on agarose gels to deduce the number of repeats in each individual locus. (4, 5) Two PCR-based typing methods, that is, double-
repetitive-element PCR (DRE-PCR) and amplityping, are designed to amplify DNA between clusters of IS6110 and polymorphic GC-rich
sequences (PGRS) or between clusters of IS6110 elements, respectively. Different distances between the repetitive elements and their different
copy numbers result in variability of banding patterns, composed of DNA fragments amplified (a–d) and produced for individual isolates. (6)
A heminested inverse PCR (HIP) depends on the amplification of the 5󸀠-end of the IS6110 sequence alongwith its upstreamflanking sequence,
bordered by the closest BsrFI site. The size and number of PCR amplicons generated depend on the number of copies of IS6110. (7) Ligation-
mediated PCR (LM-PCR) procedure allows, by introducing specifically designed linkers, amplifying the flanking sequences on both sides of
the IS6110 element. Names and positions of the PCR primers were excerpted from the original papers. For more details, read the text.
sequence on the 5󸀠 side is amplified. (In the original LM-
PCRprocedure flanking sequences on both sides of the IS6110
are amplified by using primers that are complementary to
both termini of the IS6110 sequence and one of the primers
is also complementary to the shorter strand of the linker
(Figure 1(7)) [68].)
All those methods are highly reliable and exhibit signif-
icant discriminatory potential, albeit slightly lower than that
of IS6110-RFLP analysis [59, 69–71].
This potential can even be increased when using hem-
inested inverse PCR (HIP). This method relies on amplifica-
tion of a 5󸀠 part of the IS6110 and its flanking sequence up to
the proximal BsrFI restriction site [61]. Briefly, chromosomal
DNA is cut with the restriction endonuclease BsrFI and
the restriction fragments are then self-ligated at low DNA
concentration.The resulting circular molecules comprised of
the 5󸀠-end of the IS6110 and its flanking region are subjected
to PCR using primers that anneal to the IS at sites between its
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5󸀠-end and the closest BsrFI site. Products of amplification
vary in length depending on the length of the flanking
sequence and are visualized by agarose gel electrophoresis
(Figure 1(6)). The HIP method is highly reproducible and its
discriminatory power is equivalent to that of standard IS6110-
RFLP analysis but is much simpler and faster in performance
[61, 72].
Another PCR-based IS6110 typingmethod is amplityping.
Here, outward-oriented primers hybridize with the ends of
the IS6110 sequence, so that DNA separating adjacent copies
of this element on the genome is amplified (Figure 1(5)) [73–
75]. A variant of the aforesaid method uses only a single
primer, targeted to the terminal inverted repeat sequences of
the IS6110 [76, 77]. Differences in the length of the amplicons
reflect the distance between the IS elements and are analysed
by standard gel electrophoresis. An important limitation of
this typing approach is that production of the PCR amplicons
is dependent on the priming sites within the ISs being close
enough for efficient PCR.
All PCR-based typing assays, targeting the IS6110, are
easy-to-perform, time saving and require relatively small
amounts of genomic DNA, which makes them applicable to
nonviable organisms or directly to clinical specimens, with-
out culture.The resolution of the IS6110-PCR analysismay not
be sufficient enough to differentiate among the isolates; however
when supplemented with an additional restriction digestion
step, the differentiation capacity of the method is comparable
to IS6110-RFLP [78]. Apart from some technical difficulties,
such as nonspecific priming, still the major drawback of the
methods discussed is the lack of discriminatory power for
typing of the isolates with low copy numbers of IS6110
[74–77].
6. IS-Based Typing of NTM
Since a number of different ISs have been described in various
NTMspecies, these geneticmobile elements havewidely been
applied for strain-level typing.
Two closely related insertion sequences IS1245 and IS1311
were found very useful to differentiate within the M. avium
complex.
Based on the IS1245 or IS1311-RFLP patterns, various
clades ofM. avium and its subspecies could be distinguished,
related to infections in birds, pigs, and humans [79–81].
Other insertion elements that are known and have been
used for identification rather than typing purposes of M.
avium complex bacilli include IS900 present in M. avium
subsp. paratuberculosis [82], IS901 present inM. avium subsp.
avium [83], IS902 present inM. avium subsp. silvaticum [84],
and IS666, IS1110, and IS1626, whose distribution among M.
avium isolates has been ill-studied [85–87]. The insertion
sequences: IS900, IS901, IS902, and IS1245, can be used for
the identification of various M. avium subspecies as well as
for differentiation within those subspecies.
One of the most important observations made upon
IS1245RFLP typingwas that birds are infected by a genetically
highly conserved type of M. avium strains invariably reveal-
ing the same three-band pattern, while the banding patterns
of M. avium isolates of porcine and human origin revealed
highly variable and multibanded patterns. Consequently, it
was proposed to reserve the namingM. avium-avium for the
bird-type isolates and to introduce the designationM. avium
hominissuis for typical isolates from humans and pigs [81].
Beyond the M. avium complex, RFLP typing has been
pursued only sporadically. Yet potentially useful insertion
sequences have been described in a variety of species. These
include IS1407 in M. celatum [88], IS1395 in M. xenopi [89],
IS1511/1512 inM. gordonae [90], IS2404 inM. ulcerans, IS2606
inM. ulcerans andM. lentiflavum [91], IS1652 inM. kansasii
[92], and IS6120 inM. smegmatis [93].
7. Spoligotyping
Spoligotyping is currently one of the most frequently used
PCR-based approaches for studying the phylogeography of
M. tuberculosis complex. The spoligotyping method is based
on the polymorphism at one particular genomic region,
the so-called direct repeat (DR) locus, initially identified by
Hermans et al. in the vaccine strain M. bovis BCG P3 [94].
The DR locus comprises a series of well-conserved 36 bp
direct repeats (DRs) interspersed with unique, nonrepetitive
spacer sequences of 34–41 bp. The DR and the adjacent
variable sequence form a direct variant repeat (DVR). The
DR locus belongs to the clustered regularly interspaced short
palindromic repeats (CRISPRs) family of repetitiveDNA. It is
postulated that these elements are reminiscent of centromere-
like structures with a possible role in replication partitioning
[95]. In the spoligotyping method, the entire DR locus is
amplified by PCR, using two inversely oriented primers
complementary to the sequence of short DRs. The PCR
products, of different sizes, are hybridized to a membrane
with 43 covalently bound synthetic oligonucleotides repre-
senting the polymorphic spacers identified inM. tuberculosis
H
37
Rv (spacers 1–19, 22–32, and 37–43) and M. bovis BCG
(spacers 20-21 and 33–36). The hybridization signals are
detected by chemiluminescence through biotin labeling of
the PCR products (one of the primers is biotinylated) and a
streptavidin-peroxidase conjugate system and then visualized
by autoradiography (Figure 1(2)). Individual strains are dif-
ferentiated by the number of the spacers that aremissing from
the complete 43-spacer set [62]. The lack of spacers is most
probably the result of deletions mediated by various genetic
mechanisms, such as homologous recombination or trans-
position (the DR region is a hot spot for IS6110 integration)
[96, 97].
Spoligotyping is a relatively simple, cost-effective, and
high-throughput method, whose results are accurate and
reproducible and are obtained in up to 2 days. The reliability
of the results is linked to a high stability of the DR locus. The
molecular clock of this genetic marker is believed to be very
slow, since multiple M. tuberculosis isolates from the same
patients corresponding to relapses or infections at different
sites, even over time spans of several years, showed identical
spoligotypes [98]. An important advantage of spoligotyping
is its genuine sensitivity estimated at 10 fg of chromosomal
DNA, equivalent to DNA from 2-3 bacterial cells [99],
allowing themethod to be applied directly in clinical samples,
without the need for prior culture. Moreover, spoligotyping
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has proven to be useful for typing on nonviable cultures,
Ziehl-Neelsen smear slides, or paraffin-embedded tissue
sections [100, 101].
Given the binary (present/absent) format of the data, the
spoligotyping results can easily be interpreted, computerized,
and compared between different laboratories [102].
In 2006, an international spoligotyping database
(SpolDB4) was released. The database, which is accessible
online (http://www.pasteur-guadeloupe.fr:8081/SITVIT-
Demo/), describes 1,939 STs (shared types, i.e., spoligotype
patterns shared by two or more isolates) and 3,370 orphan
types (i.e., spoligotype patterns reported for only single
isolates) from a total of 39,295 M. tuberculosis complex
isolates, from 122 countries, classified temporarily into 62
clades/lineages [103]. In a recently erected publicly available
multimarker database named SITVIT, a total of 7105 spoli-
gotype patterns (corresponding to 58,180 clinical isolates)—
grouped into 2740 shared types containing 53,816 clinical
isolates and 4364 orphan patterns—were incorporated
(http://www.pasteur-guadeloupe.fr:8081/SITVIT ONLINE/)
[104].
Spoligotyping allows identification of M. tuberculosis
complex isolates at the (sub)species level. For instance, the
M. tuberculosis spoligotypes are characterized by the absence
of spacers 33–36, whereas M. bovis spoligotypes usually lack
spacers 39–43, and M. bovis BCG spoligotypes lack spacers
3, 9, and 16 [105]. Furthermore, spoligotyping allows iden-
tification of genotypes of significant, clinical, and epidemi-
ological relevance. A clear example is the “Beijing” genotype,
commonly encountered in the Beijing area, other regions of
Asia, the former Soviet Union, and other geographical areas.
Most of the “Beijing” genotype strains react only with the last
9 spacers (35–43) in the panel of 43 [105].
Spoligotyping has a lower level of discrimination than the
IS6110 RFLP typing, as evidenced in several studies [70, 106–
110]. The introduction of 51 novel spacer sequences, mostly
[45] from the DR region from the M. canetti genome only,
slightly improved the resolution of the method [97]. The 68-
spacer format, with 25 out of 51 new spacers, was shown to
improve the discrimination for the M. africanum subspecies
and for the East African-Indian (EAI) clade ofM. tuberculosis
[111, 112].
The reason for the limited discriminatory capacity of the
spoligotyping method is due to the fact that it targets only a
single genetic locus, covering less than 0.1% of the M. tuber-
culosis complex genome. Nevertheless, spoligotyping can be
effectively used for the differentiation of M. tuberculosis
strains with low IS6110 copy numbers (≤5 bands in RFLP pat-
terns) [54, 113]. As M. tuberculosis isolates with different
spoligotypes invariably have distinct IS6110 RFLP profiles, a
genotyping strategy has been proposed, in which spoligotyp-
ing could be performed as a first-line, screening test, to be
followed by another typing method of greater discriminatory
power [108]. Spoligotyping, when used alone, is not sufficient
for epidemiological linking studies. Furthermore, contami-
nated isolates and multistrain infections may not be detected
by performing spoligotyping directly on clinical samples.
However, this remark can be extended to any PCR-based
technology, which is applied directly in clinical material.
Spoligotyping, when applied for nontuberculous myco-
bacteria, produced no signal, indicating the specificity of the
method solely forM. tuberculosis complex [108].
Since the description of the spoligotyping method in its
original form, another two formulations have been proposed.
The first benefits from the Luminex technology, where the
synthetic spacer oligonucleotide probes are immobilized on
microspheres by means of covalent coupling, and detection
is achieved via fluorochromes attached to the beads and
hybridized PCR product. The Luminex platform, by elimi-
nating the membrane step with the subjective manual data
interpretation, provides, greater robustness and reproducibil-
ity. It is also well suited for high-throughput analysis, since it
allows 96 isolates to be assayed simultaneously, as opposed to
45 isolates in a standard spoligotyping approach [112, 114].
Amore recent alternative to a conventional spoligotyping
scheme is a new multiplexed primer extension-based spolig-
otyping assay using automated matrix-assisted laser desorp-
tion ionization-time of flight mass spectrometry (MALDI-
TOF MS). Spoligotyping by MALDI-TOF MS improves the
classical reverse line blot hybridization assay with respect
to reproducibility, throughput, process flow, ease of use,
and data analysis [115]. An important limitation of these
innovative, technologically refined spoligotyping assays is
that they require advanced and expensive equipment which
many laboratories, especially those in resource-constrained
settings, cannot afford.
8. Methods Based on Minisatellite Sequences
Mycobacterium tuberculosis was among the first bacterial
species in which tandem repeat loci resembling minisatellite
loci in eukaryotic genomes were identified. The mycobac-
terial tandemly repeated sequences were, per analogiam to
those in humans and animals, called variable number of tan-
dem repeat (VNTR) loci. However, as new VNTR-type loci
have been discovered, they have been referred to under
different names.
The first described VNTRs were major polymorphic
tandem repeat (MPTR) and exact tandem repeat (ETR),
found in 5 (A–E) and 6 (A–F) loci, respectively [63]. The
MPTR consists of a 10 bp repeated sequence separated by
unique 5 bp spacer sequences.These repetitiveDNAelements
were identified in M. tuberculosis complex as well as in
other mycobacteria, including M. gordonae, M. kansasii, or
M. szulgai [116]. The MPTR has been shown particularly
useful in typing of M. kansasii. RFLP analysis with MPTR
as a probe has revealed the existence of multiple subtypes
within this species [92].These subtypes have later been shown
to have different degrees of pathogenicity in humans [117].
Interestingly, the MPTR sequences are part of the 3󸀠-end
of genes belonging to the PPE proteins (named after the
conserved Pro-Pro-Glu (PPE) motifs near the N terminus of
themolecule).Thepolymorphismof the PPEproteins in their
C-terminal domains, linked to the presence of the MPTR
motifs, is speculated to be the source of antigen variability
inM. tuberculosis [118].
The ETR elements, found exclusively in M. tuberculosis
complex strains, contain repeats ranging in size from 53 to
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79 bp. Sequencing of the ETRs revealed that all of the ETR
loci were variable. Contrastingly, amongMPTR loci, only one
(MPTR-A) showed some polymorphism, upon sequencing
analysis [63]. Of eleven MPTR/ETR loci, only five (ETR-
A–E) are routinely used for genotyping of M. tuberculosis
strains. The principle of any typing system based on the
polymorphismofVNTR loci is that eachVNTR locus is PCR-
amplified with specific primers complementary to the flank-
ing regions, and the resulting PCR products are visualized
by standard gel electrophoresis (Figure 1(3)). The number of
tandem repeat units is determined by estimating the size of
the amplicons, in relation to the known size of the repeat unit
within the targeted VNTR locus. The results are expressed in
a simple, digital format, in which each digit represents the
number of copies at a particular locus [63]. Despite being
fast, easy-to-perform, and highly reproducible, VNTR geno-
typing based on 5 ETR loci has a low discriminatory power,
compared to IS6110-RFLP or spoligotyping [53, 70, 119, 120].
However, with the completion of the M. tuberculosis H
37
Rv
genome sequencing project, new VNTR-type loci have been
identified. A specific class of these new VNTR elements is
mycobacterial interspersed repetitive units (MIRUs). MIRUs
were originally described by Supply et al. [121] as 46–
101 bp tandem repeats scattered at 41 loci throughout the
chromosome ofM. tuberculosisH
37
Rv. Based on the sequence
analysis of each of those loci, 12 were found to display
variations in tandem repeat copy numbers and were thus
selected for genotyping of M. tuberculosis isolates [122,
123]. Among those 12 hypervariable loci, two (MIRU-4 and
MIRU-31) are identical to formerly described ETR loci (i.e.,
ETR-D and ETR-E, resp.). MIRU-VNTR analysis, as every
VNTR-based typing approach, involves PCR amplification
of a specific MIRU locus, followed by determination of
the sizes of the amplicons by gel electrophoresis or, after
running multiplex PCRs, on an automated, fluorescence-
based sequencer (Figure 1(3)). Since the length of the repeat
units is known, the calculated sizes reflect the numbers of
the amplified MIRU copies. The final result is a multidigit
numerical code (the so-called MIRU-VNTR code), cor-
responding to the repeat number at each analyzed locus
[64, 124]. This coding system allows the results to be readily
compared across laboratories worldwide and facilitates the
data to be deposited in the global databases via the Inter-
net for large-scale epidemiological and population genetic
studies [125, 126] (http://www.miru-vntrplus.org/). Recently,
the biggest publicly available international database named
SITVITWEB, which incorporates multimarker genotyping
information (i.e., based on MIRU-VNTR typing and spolig-
otyping) on 62,582 M. tuberculosis complex clinical isolates
from 153 countries of patient origin, has been released (http://
www.pasteur-guadeloupe.fr:8081/SITVIT ONLINE/) [104].
Furthermore, a 12-locus MIRU scheme, based on the mini-
mum spanning tress (MST) method, has been proposed for
classification of M. tuberculosis complex genotypic lineages
[127].
TheMIRU-VNTRmethod is a reliable and efficient typing
system, whose discriminatory capacity approximates or even
exceeds that of IS6110-RFLPprofiling. In general, the discrim-
inatory power of MIRU-VNTR analysis increases with the
number of loci evaluated. MIRU-VNTR typing based on 12
loci is slightly less discriminatory than IS6110-RFLP analysis
for M. tuberculosis isolates with high copy number of IS6110
[64, 123, 128, 129] but at the same time more discriminatory
than the IS6110-RFLP if low-copy-number IS6110 isolates are
investigated [130, 131]. In principle, 12-locus MIRU-VNTR
cannot be used as a sole typingmethod, as itmay overestimate
the number of true epidemiological links, especially in large,
population-based studies [132, 133]. Consequently, it is sug-
gested to use 12-locus MIRU-VNTR analysis in combination
with other genotypingmethods [128, 132]. An alternative way
is to increase its resolution by expanding the investigation on
other polymorphic VNTR loci.
The observed heterogeneity of the VNTR domains (they
are still being discovered in the tubercle bacilli genome)
provides great flexibility in designing new marker combina-
tions that would enhance the discriminatory capacity of the
genotyping method. In 2006, a new system employing 24
MIRU-VNTR loci (including 12 previously investigated) has
been proposed [124]. Noteworthy, 15 (including 6 previously
investigated) of those 24 loci account for 96% of all detected
polymorphisms inM. tuberculosis strains.Thediscriminatory
power of this new, 24-locus MIRU-VNTR typing system
equals that of IS6110-RFLP profiling [125, 134, 135]. This
has rendered 24-locus MIRU-VNTR typing the new gold
standard in molecular typing of M. tuberculosis complex
bacteria. Next to the proposed standardized MIRU-VNTR
15- or 24-loci sets, the use of another three loci, the so-
called hypervariable loci (i.e., VNTRs 3232, 3820, and 4120),
is recommended as a second-line typing step, particularly to
differentiate Beijing genotype strains.
Overall, genotyping based on minisatellite sequences is a
rapid, sensitive, and highly discriminating approach, which
makes it well suited for large-scale investigations. A particular
advantage of the VNTR genotyping, compared to the IS6110-
RFLP typing, is its portability due to digitalization of the
generated patterns and therefore simple intra- and interlab-
oratory comparability as well as the amenability to inclusion
in web-based databases. Reproducibility of the method was
expected to be good, due to the genetic stability of the targeted
loci; yet, in the first worldwide proficiency study, both intra-
and interlaboratory reproducibility proved to be suboptimal.
Further harmonization of the laboratory methodology is still
needed [136].
The occurrence of VNTR loci in the genomes of non-
tuberculous mycobacteria remains largely obscure. Eight
MIRU-VNTR-type loci have recently been described by
Thibault et al. inMycobacterium avium andM. avium subsp.
paratuberculosis [137]. In Japan, a refinedVNTR typingmeth-
od using theM. avium tandem repeat (MATR) loci (MATR-
VNTR) has been employed [138]. InM. intracellulareDauchy
et al. identified 45 potential MIRU-VNTR loci, 7 of which
showed enough variability to be used as strain-level discrimi-
natorymarkers [139].The discriminatory power of theVNTR
typing assays, based on the newly discovered loci in both
species, was considered promising [80, 137, 139]. Recently, 13
VNTR loci have been described and applied to confirm clonal
relationships between patient and environmental isolates of
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M. ulcerans [140]. Twelve VNTR loci have been defined and
tested againstM. marinum isolates [141].
9. Methods Based on GC-Rich Sequences
The genome of M. tuberculosis has a particularly high GC
content (>65.5%). The polymorphic GC-rich repetitive
sequences (PGRS) are the most abundant type of repeti-
tive DNA in the genome of M. tuberculosis complex. The
PGRS elements occur at multiple loci and consist of several
repeats of a 9 bp consensus sequence (5󸀠-CGGCGGCAA-3󸀠),
tandemly arranged in up to 1.5 kb segments. Although the
PGRS were initially identified in M. tuberculosis complex,
they are now known to be present in other mycobacterial
species, such as M. kansasii, M. gastri, and M. szulgai [142].
The PGRS bear important resemblance to the aforedescribed
MPTRs. The similarities between those repetitive elements
include host range, structure, genetic stability, and copy num-
ber across the mycobacterial genome [143]. Furthermore,
PGRS, like MPTR sequences, are part of protein-coding
regions. Multiple tandem repetitions of the PGRS-encoded
motif AsnGlyGlyAlaGlyGlyAla are found in glycine-rich
proteins with a characteristic proline-glutamate (PE) residue
group at the N terminus of the peptide. Members of the PE-
PGRS family of proteins, analogously to PPE-MPTR protein
family, are suspected to play a role in antigenic variability
[118].
Since the number of the PGRS element and its distribu-
tion vary in different strains, it has been applied as a genetic
marker for typing of M. tuberculosis. The most extensively
used method utilizing this marker is PGRS-RFLP, the pro-
cedure of which is quite the same as that for the IS6110-RFLP,
except that the chromosomalDNA is cut withAluI restriction
endonuclease, instead of PvuII, and that a 3.4 kb fragment
of the PGRS sequence, cloned in a recombinant plasmid
pTBN12, is used as a probe in a hybridization step [142]. The
PGRS-RFLP analysis or pTBN12-RFLP fingerprinting has
been shown to have a relatively high discriminatory power,
especially for IS6110 low-copy-number strains [56, 144, 145].
The pTBN12 fingerprinting method has similar limitations as
the IS6110-RFLP typing, but additionally the hybridization
patterns produced by PGRS typing are more complex and
difficult in interpretation. A second method which benefits
from the polymorphism of the PGRS sequence is double-
repetitive-element PCR (DRE-PCR). This method relies
upon amplification of the DNA segments located between
IS6110 sequences and the PGRS sequences, by using primers
directed outwards from the ends of both these repetitive
elements (Figure 1(4)). Based on the distance between IS6110
and PGRS sequences and the copy number of these elements
which differs between the strains, DRE-PCR yields strain-
specific amplification patterns [65]. Although highly discrim-
inative, the method suffers from poor reproducibility and a
strong bias in the interpretation of the results [65, 146, 147].
A similar approach as that reported for DRE-PCR
was used to design another typing method, called IS6110-
ampliprinting [66]. In brief, the method measures the vari-
ability in the distances between IS6110 elements and copies
of MPTR sequences of M. tuberculosis, through unilateral-
nested PCR with IS6110 and MPTR targeted primers, fol-
lowed by hybridization with an IS6110-specific probe. The
method, however, has not been widely adopted, mainly due
to the limited number and size of generated PCR products
[70].
A recent method that harbors GC-rich sequences, the
IS6110-Mtb1-Mtb2 PCR typing, is guided by a similar prin-
ciple as that involved in DRE-PCR profiling. Two PCR assays
are performed with primers of two kinds, that is, primers
complementary to terminal inverted repeats (TIR) flanking
the IS6110 sequences and primers complementary to short
(16 bp) GC-rich motifs, called Mtb1 (I PCR) and Mtb2 (II
PCR). As a result, fragments of DNA located between Mtb1
and Mtb2 as well as between each of those elements and
IS6110 sequences are amplified [67]. Although the IS6110-
Mtb1-Mtb2 PCR method has not been exploited sufficiently,
the results from the insofar performed studies suggest its
usefulness in the molecular epidemiological investigations of
TB. Most notably the discriminatory power of this method
has been demonstrated as almost equivalent to that of IS6110-
RFLP typing [67, 148, 149].
Although PGRS is not commonly being applied for strain
typing of NTM, RFLP analysis with PGRS isolated from M.
tuberculosis as a probe was successfully used to differentiate
isolates of the species of M. kansasii [150] and M. ulcerans
[151].
10. Repetitive Sequence-Based- (rep-) PCR
Every genotyping method, whose principle is based on the
PCR amplification of DNA sequences between repetitive
DNA elements, is referred to as repetitive sequence-based-
(rep-) PCR. By using primers designed as extended away
from the repetitive sequence elements, multiple amplified
fragments are generated, depending on the sequence length
between the repetitive elements. The amplified fragments
produce a fingerprint pattern upon gel electrophoresis. IS6110
amplityping, DRE-PCR, IS6110-ampliprinting, and IS6110-
Mtb1-Mtb2 PCR, all thesemethods are representatives of rep-
PCR technology. A long list of various repetitive elements
that have been applied for genotyping ofM. tuberculosis and
nontuberculous mycobacteria includes also DNA sequences
that lack species or even genus specificity, such as enterobac-
terial repetitive intergenic consensus (ERIC) and the (GTG)
5
sequences [152–155].
Recently, a commercially available rep-PCR system
(DiversiLab System, bioMe´rieux, France) has been adapted
for use on mycobacteria. The DiversiLab System, which
takes advantage of various repetitive elements interspersed
throughout different bacterial genomes, was evaluated on a
collection of M. tuberculosis and M. avium complex isolates
[156, 157] as well asM. abscessus isolates [158]. ForM. tuber-
culosis andM. avium subsp. avium, the discriminatory ability
of the assay equaled or exceeded that of IS6110-RFLP and
IS1245-RFLP [156, 157, 159]. In more recent reports, rep-PCR
was successfully used to disclose the source of infection in
a patient with hypersensitivity pneumonitis caused by M.
avium [160].
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11. Random Amplified Polymorphic DNA
(RAPD) Analysis
Random amplified polymorphic DNA (RAPD) analysis, also
referred to as arbitrary primer PCR, depends on amplification
of random fragments of genomic DNA using arbitrarily
designed primers (5 to 50 bp) under low stringency condi-
tions.The interstrain polymorphism is assessed by comparing
the electrophoretic pattern of the PCR products. Although
the method provides high discriminatory power, a number
of limitations exist for this technique, of which the apparent
lack of reproducibility is the most important. This is because
differences between the strain patterns generated by RAPD
are due to technical and operating parameters of the method
rather than true interstrain genetic polymorphism.Variations
in RAPD patterns are chiefly attributed to variations in
the priming efficiency during early rounds of amplification,
and these in turn depend on template concentration and
purity, primer/template ratio, or the ramp times of the
cyclers used. Nonetheless, the RAPD typing has been used
to differentiate among isolates of M. tuberculosis complex
isolates [161–164] as well as among isolates of numerousNTM
species, includingM. abscessus [165],M. phocaicum [166],M.
gordonae [167],M. szulgai [168], andM. malmoense [169].
The RAPD analysis is usually performed on the entire
genomicDNA; however in somemodifications of themethod
only a fragment of the bacterial chromosome is used as
a substrate for PCR. Such a strategy was employed for
genotyping ofM. tuberculosis strains by Abed et al., who used
the 16–23S rDNA internal transcribed spacer (ITS) region
within the rDNA operon as a target for PCR.The subsequent
RAPD analysis of the amplified product resulted in highly
polymorphic and easily interpretable profiles [170]. Still, the
reproducibility of this RAPD-based method was found to be
poor [171, 172].
12. Amplified Fragment Length Polymorphism
(AFLP) Analysis
Amplified fragment length polymorphism (AFLP) analysis
is a PCR-based method in which genomic DNA undergoes
digestion with two restriction enzymes, a rare cutter and
a frequent cutter, typically having six- and four-nucleotide-
long recognitions sites, respectively (e.g., EcoRI and MseI,
resp.), followed by ligation of two types of synthetic, double-
stranded adaptors (10–30 bp) to the generated cohesive ends
of DNA fragments. Amplification of a subset of restriction
fragments is achieved by PCR with primers complementary
to the adaptor sequence, the restriction site sequence, and a
few nucleotides (1–3) extending beyond the restriction site.
The amplicons are separated and visualized on denaturing
polyacrylamide gels, usually through autoradiography, as the
primers are radioactively labeled [173]. The conventional
radioactive AFLP method has a lower discriminatory poten-
tial than IS6110-RFLP typing [174, 175]. However, the AFLP
technology provides an extraordinary flexibility in designing
the typing protocols of enhanced power of discrimination.
Here, the choice of restriction endonucleases and the degree
of primer selectivity may largely determine the final resolu-
tion of the method.
A refinement of the traditional AFLP assay is the fluores-
cent (f)AFLP, where the subsets of the DNA digestion frag-
ments are PCR-amplified with five primers, a single, nonse-
lective, unlabeled forward primer targeting theMseI adaptor
site and four reverse primers, targeting the EcoRI adaptor
site, each containing the selective base A, G, C, or T, labeled
with different fluorescent dyes. The amplified fragments are
resolved by electrophoresis on an automated DNA sequencer
and precisely sized using internal size standards [176]. Apart
from the improved occupational safety, the discriminatory
potential of fAFLP is higher than that of the radioactive AFLP
and comparable to that achieved by IS6110-RFLP [176, 177].
The AFLP method has successfully been applied to
various NTM species including theM. avium complex [178],
M. haemophilum [179], and M. marinum and M. ulcerans
[180], although its exact discriminatory power in larger sets
of isolates has never been assessed.
Furthermore, AFLP analysis has clearly distinguished
betweenM.marinum andM. ulcerans, conforming that these
species which are difficult to distinguish by conventional
methods, are genetically distinct [180, 181].
13. Multilocus Sequence Typing (MLST)
Genetic polymorphism between and within different myco-
bacterial species can also be investigated at the nucleotide
sequence level. Such a concept gave rise to a new typing sys-
tem, the so-calledmultilocus sequence typing (MLST), which
evolved directly from the multilocus enzyme electrophoresis
(MLEE or MEE) technique. Unlike MLEE, which targets
the electrophoretic mobility of slowly evolving metabolic
enzymes (usually 15 to 25), isolated from each bacterial iso-
late, MLST targets the sequences of a small number (up to
10) of housekeeping genes coding for vital enzymes and
structural proteins. Although bothMLEE andMLST schemes
failed to reveal sufficient polymorphism among members of
the M. tuberculosis complex [27, 182], these techniques were
found useful for differentiation of various NTM species. For
instance, by using MLEE, polymorphism was found among
isolates of theM. avium-M. intracellulare complex [183–185].
On the other hand, the MLST analysis, based on 10 genetic
loci, allowed the determination of the variability between
subspecies and strains ofM. avium and thus greatly improved
our knowledge on genetic divergence and evolution of this
group of NTM [186]. MLST has also proven to be valuable in
investigations of NTM in laboratory outbreak settings [166].
Given the low degree of sequence polymorphisms in M.
tuberculosis complex, standard MLST is poorly informative
and inefficient. Its place has now been taken over by a
new typing strategy based on analysis of single nucleotide
polymorphisms (SNPs).
14. Single Nucleotide Polymorphism
(SNP) Typing
Single nucleotide polymorphisms (SNPs) fall into two major
groups: synonymous- (s-) SNPs and nonsynonymous- (ns-)
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SNPs.The latter, if present in coding regions, introduce amino
acid changes to the proteins. This in turn may influence
the phenotype and be subjected to selection pressure. For
instance, ns-SNPs are implicated inM. tuberculosis resistance
to anti-TB drugs (drug resistance in M. tuberculosis is
almost invariably associated with mutations (nonsynony-
mous point mutations, small deletions, and duplications) in
specific, chromosomal loci) [187]. Screening for ns-SNPs in
resistance-conferring genes provides important insights into
themolecularmechanisms and dynamics of the development
of drug resistance.
Contrariwise, s-SNPs do not alter the amino acid profiles
and are thus phenotypically neutral. As s-SNPs are also
believed to be evolutionary neutral, they are used for pop-
ulation genetics and for studying phylogenetic relationships
among mycobacterial strains [188, 189]. A picture of the
phylogenetic population structure of M. tuberculosis has
recently been inferred by using a combination of s-SNP and
non-SNP markers. Based on the SNPs at codon 463 of the
katG gene and codon 95 of the gyrA gene, Sreevatsan et
al. divided M. tuberculosis complex into 3 principal genetic
groups (PGG1–PGG3) [14]. Those three PGG groups were
further split into 9major clusters (I–VIII and II.A) by analysis
of additional 36 s-SNPs [189]. Recently, Dos Vultos et al. [190]
have indicated SNPs in the 56 genes encoding 3R (DNA
replication, recombination, and repair) system components
as the key genetic markers to study the evolution of M.
tuberculosis.
Although SNPs represent the most reliable markers for
lineage classification of MTBC, their use is hampered by the
need to test a large set of genes to achieve satisfactory
resolution. Recently, Homolka et al. [16] have developed a
SNP-based diagnostic algorithm allowing the identification
of 17 MTBC phylogenetic lineages with high specificity. The
algorithm involves sequence analysis of only five genes. The
SNP typing approach is highly specific and sensitive, although
SNP analysis has predominantly been used in genealogy,
phylogenetic, and population genetics studies.
15. Deletion Mapping and Deligotyping
Comparative genomic studies of different strains of M.
tuberculosis (e.g., H
37
Rv, CDC1551) have proven that the loss
of genetic material has stigmatized the evolutionary history
of that species. Genomic deletions, also known as large-
sequence polymorphisms (LSPs) or regions of difference
(RD), have been detected across theM. tuberculosis genomes
[191, 192]. For example, a total of 68 distinct deletions, ranging
in size from 105 bp to approximately 12 kb, were found in
100 M. tuberculosis clinical isolates [192]. Deletions are not
randomly distributed but rather appear in aggregations.They
occur within both intra- and intergenic regions [191–194].
Noteworthy, almost half of the LSPs identified in M. tuber-
culosis H
37
Rv and CDC1551 strains involved genes encoding
PPE and PE family proteins [191]. Since LPSs have emerged
as a significant source of interstrain genetic variability, they
have been used as markers for genotyping. Analysis of chro-
mosomal deletions has been shown as an extremely attrac-
tive approach for studying the phylogeny and evolution of
M. tuberculosis complex [192, 195, 196]. Deletion analysis,
also referred to as deligotyping, can be performed either by
a simple PCR-based method or by automated microarray
techniques. The resolution of the method can greatly be
increased if specific sequences flanking each side of the
deletion element are known. Recently, a high-throughput
method for distinguishing LSPs was invented. Both the con-
cept and procedure of this method were patterned upon the
spoligotyping technique. Here, deletion events are detected
in 43 genomic loci by amplifying them in a multiplex PCR
assay and subjecting the amplicons to hybridization with a
set of 43 probes, whose sequences directly correspond to the
targeted loci [197]. Deligotyping is a very sensitive and effi-
cacious approach for rapid screening of clinical isolates ofM.
tuberculosis. The method is also well suited for constructing
robust phylogenetic relationships [198].
16. Concluding Remarks
As described above, there is a wide range ofmethods available
for genotyping ofM. tuberculosis complex and NTM species
(Tables 1 and 2). Each method has its own benefits and short-
falls, and none of them have proven clearly superior to any of
the others. The choice of the optimal typing system depends
heavily on the sample under investigation, the setting in
which typing is performed, and the expected outcome. For
instance, spoligotyping is of particular value in population-
based studies to define the phylogeographic specificity of
circulating clades of tubercle bacilli. However, to assess the
genetic relatedness and the epidemiological links among TB
outbreak-related cases, the IS6110-RFLP or MIRU-VNTR
typing is preferably chosen. Again, whereas spoligotyping
is recommended as a preliminary screening test of a large
number ofM. tuberculosis isolates, disclosure of true genetic
relationships between the isolates requires more discriminat-
ing methods, such as MIRU-VNTR typing, to be performed
within the spoligotype-defined clusters.
An ideal molecular typing method should accommodate
the requirements with respect to both performance and ana-
lytical criteria. The desired performance parameters include
technical simplicity (easiness of performance), reproducibil-
ity, robustness, and time and cost effectiveness. An attractive
feature of the method could be its applicability directly to
clinical material. Another special advantage is a standardized
and easily portable and interpretable format of the results
(e.g., digital codes), facilitating databasing and interlabora-
tory comparative studies. As for the analytical parameters, the
most important are the level of discrimination and stability of
the genetic marker used. The general rule that the higher the
discriminatory power of a givenmethod, themore reliable the
results obtained guides most of the molecular epidemiology
investigations. However this may not always be the case. The
validity of such assumption depends on several issues related
to clustering, such as the characteristics of the study setting,
the proportion of cases included (completeness of sampling),
or the period of case recruitment (duration of the study). In
other words, a number of important considerations have to
be taken into account when choosing an appropriate typing
methodology in terms of discrimination capacity.
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Table 1: Selected typing methods forMycobacterium tuberculosis complex and level of genetic polymorphism they reveal.
Typing method DNA target Polymorphism References∗
IS6110-RFLP
IS6110
High van Embden et al., 1993 [48]
ML-PCR High Haas et al., 1993 [58]
FliP High Reisig et al., 2005 [59]
LM-PCR High Prod’hom et al., 1997 [60]
HIP High Kearns et al., 2000 [61]
Spoligotyping DR locus Low Kamerbeek et al., 1997 [62]
VNTR typing ETRs A–E Low Frothingham and Meeker-O’Connell, 1998 [63]
MIRU-VNTR typing MIRUs High Supply et al., 2001 [64]
DRE-PCR IS6110/PGRS High Friedman et al., 1995 [65]
IS6110-ampliprinting IS6110/MPTR High Plikaytis et al., 1993 [66]
IS6110-Mtb1-Mtb2 PCR IS6110/Mtb1/Mtb2 High Kotlowski et al., 2004 [67]
∗Papers with original description of a given method.
RFLP: restriction fragment length polymorphism; ML-PCR: mixed linker PCR; FliP: fast ligation-mediated PCR; LM-PCR: ligation-mediated PCR; HIP:
heminested inverse PCR; VNTRs: variable numbers of tandem repeats; MIRU: mycobacterial interspersed repetitive units; DRE-PCR: double-repetitive-
element PCR; DR: direct repeat; ETR: exact tandem repeat; PGRS: polymorphic GC-rich sequence; MPTR: major polymorphic tandem repeat.
Table 2: Discriminatory power of selected typing methods for
Mycobacterium tuberculosis complex and nontuberculous mycobac-
teria and level of genetic polymorphism they reveal.
Typing method MTBC NTM
RFLP High Insufficient data
RAPD Medium High
PFGE Medium High
AFLP High Insufficient data
Spoligotyping Low/diverse None
MIRU-VNTR typing High/diverse Insufficient data
MTBC:Mycobacterium tuberculosis complex; NTM: nontuberculous myco-
bacteria; RFLP: restriction fragment length polymorphism; RAPD: random
amplified polymorphic DNA; PFGE: pulsed-field gel electrophoresis; AFLP:
amplified fragment length polymorphism; MIRU-VNTR: mycobacterial
interspersed repetitive unit-variable number of tandem repeats.
The discriminatory power of molecular markers is
directly linked to the genetic stability of each marker. There
have been observed minor changes in DNA fingerprint pat-
terns of M. tuberculosis strains isolated not only from epi-
demiologically related TB cases, but also from the same
patient at different points of time [52, 199–202]. The stability
of the genotypic patterns over time reflects the evolutionary
rate, also referred to as a “molecular clock,” of each genetic
marker. For example, a half-life of the IS6110-RFLP profiles
has been shown to be much shorter than that of the spoligo-
type profiles [70, 98]. Likewise, the combinedmolecular clock
of the MIRU-VNTR loci has been shown to be slower than
that of IS6110-RFLP [203]. In general, the best molecular
marker is the one, whose “molecular clock” is, on the one
hand, fast enough to distinguish unrelated cases and, on the
other hand, sufficiently slow to capture epidemiologically
linked cases [204]. Markers evolving rapidly and those evolv-
ing at slow ratesmay either underestimate or overestimate the
amount of recent transmission of the disease, respectively.
The choice of a genotyping method, with respect to its
discriminatory ability, depends on the type of research in
question. Whereas a highly discriminatory method, that is
with a fast “molecular clock,” would be required to determine
whether an infection is a reactivation of an infection acquired
in the past (latent infection) or rather a reinfection with a
new strain, a method with a slow “molecular clock” would be
needed for global strain tracking and evolutionary studies.
The resolution power of different typing methods, yield-
ing very diversified genetic patterns, has had an impact on the
definition of clustering. Indeed, there persists a controversy in
the literature on whether or not isolates whose patterns show
subtle differences, that is, of 1-2 bands, in the IS6110-RFLP
patterns or single locus variations (SLVs) in theMIRU-VNTR
patterns may be regarded as part of a genetic cluster and thus
constitute an ongoing chain of transmission. Whereas some
authors apply a strict cluster definition including only isolates
with identical genotypes [134, 135, 205, 206], the others advo-
cate the use of slightly relaxed criteria for defining clusters,
with a tolerance of a single- or double-band difference in the
RFLP profiles and/or SLVs or double locus variations (DLVs)
in the MIRU-VNTR profiles [52, 200, 207, 208]. With the
latter approach, another important question arises, that is,
to what extent the fingerprint patterns of two isolates may
differ before they are no longer considered to be clustered.
Since no clear cut-offs exist for defining a cluster, the decision
which isolates should be included or excluded from clusters is
largely a matter of arbitrariness. In general, the more lenient
the assumed criteria, the higher the chance of detecting
clusters, but the lower the likelihood that a cluster represents
epidemiologically related cases [209].
One has also to be mindful that the identity or high simi-
larity of DNA fingerprints from two individuals, obtained by
using even the most discriminating techniques, may not
always mean a recently transmitted infection. Other expla-
nations are possible, including the simultaneous reactivation
of a previously acquired infection with the same organism
(coincidence of time), the regional predominance of a partic-
ular strain, circulating over a long time, or a laboratory cross-
contamination [210].
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Sample
Microscopy
MGIT960
liquid culture
Rapid immunochromatographic tests
(distinction between MTBC versus NTM)
Genotype 
mycobacteria
direct test
Direct detection 
of 5 clinically relevant 
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Identical genotypic patterns may not indicate clonality,
even when multiple genetic markers are employed. This was
best evidenced byNiemann et al. who compared the complete
genomes of two M. tuberculosis Beijing genotype isolates
from a high-incidence region (Karakalpakstan, Uzbekistan),
of which one was drug susceptible and the other was mul-
tidrug resistant. Both isolates shared the same IS6110-RFLP
pattern and the same allele at 23 out of 24 MIRU-VNTR loci,
yet they differed by 130 SNPs and one large deletion [211].This
finding implies some important messages. First, M. tubercu-
losis isolates exhibiting identical DNA fingerprinting profiles
may still display substantial genomic diversity. This in turn
may lead to misinterpretation of the extent of TB transmis-
sion in a community or invalid differentiation between dis-
ease relapse and exogenous reinfection, when using standard
genotyping tools. It seems that the optimal option to fully
explore the phylogenetic branching and variation on strain
level and to justifiably draw epidemiological conclusions
on the etiology, host-range, and transmission of TB dis-
ease would be the application of whole-genome sequencing
(WGS) analysis. Although still an expensive solution, with
the plummeting cost of DNA sequencing, the WGS may
become an omnipotent approach to replace all previously
knowndiagnostic tests forM. tuberculosis, including those for
identification or drug susceptibility profiling [212]. As for the
present, a status of the “gold standard” typing method forM.
tuberculosis is still being held by the IS6110-RFLP. However,
it is being increasingly replaced by the MIRU-VNTR typing,
not only because its discriminatory power equals that of
IS6110-RFLP but only because it has methodological and
practical advantages over RFLP, most important of which is
that the PCR-based typing method requires fewer bacteria
and consequently shortens considerably delay in obtaining
genotypes. Thus, the MIRU-VNTR typing can be regarded as
the new standard for TB molecular epidemiology.
As for the NTM, a number of genotyping methods are
available, most of which were first applied to M. tuberculosis
complex and then turned out to work for specific NTM
species, but the discriminatory power of those methods has
not been fully examined. A method most commonly applied
in various NTM species, with only slight species-specific
modifications, has been PFGE typing. Due to its wide use, it
could be considered the “gold standard” for all NTM species
except forM. avium. For the latter, IS1245 RFLP typing is the
widely recognized reference method [79]. MLST has also the
potential to become a reference method, although its wider
use is hampered by limited access and high costs of the
sequencing facilities. However, with the level of genetic diver-
sity in NTM (sub)species being ill-defined and the discrim-
inatory power of most of the markers not fully established,
for a proposal of the “gold standard” typing system for
NTM species to be delivered, further studies are required
(Figure 2).
Although there is currently no genotyping method that
would work in diverse settings and population groups or to
be equally effective at answering particular epidemiological
questions, the application of molecular typing methods has
significantly advanced our knowledge of the transmission
and pathogenesis of mycobacteria.
Molecular typing methods have permitted investigation
of the outbreaks [36, 61, 100, 139, 165, 166, 213, 214], dis-
crimination between exogenous reinfection and endogenous
reactivation [209, 210, 215–217], identification ofmixed infec-
tions [215, 218, 219], and cases of misdiagnosis due to lab-
oratory contamination [220–223]. Molecular markers have
also extensively been used for tracking transmission patterns
within specific populations and/or defined geographical set-
tings [106–108, 153, 206, 224–227]. Finally, genotyping meth-
ods have shed important light on the phylogeny and evolu-
tionary history of the mycobacterial species [12, 14, 189, 194].
Methods of molecular typing constitute an integral ele-
ment of virtually all epidemiological studies onmycobacterial
infections.They continue to substantially improve our under-
standing of the biology of mycobacteria and are believed to
provide novel and powerful tools to combat and/or protect
against the diseases caused by these pathogens.
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